Clinical Study | Office of Clinical Research

Long-Term Study Evaluating The Long-Term Safety And Tolerability Of Once Daily Centanafadine Capsules In Children And Adolescents With Attention-Deficit/Hyperactivity Disorder

Posted Date: Feb 7, 2022

Long-term Safety of Centanafadine in Children and Adolescents With Attention-deficit/Hyperactivity Disorder

Males And Females Aged 4 To 17 Years

Adhd, Attention, Kids

Bhavana Ramachandran
(513) 558-4413
ramachba@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List